Kielo Research is a boutique research consultancy delivering patient-centered scientific services for drug and medical device development. With 50+ years of combined expertise and 100+ peer-reviewed publications, our team applies global thought leadership in patient preference studies, benefit-risk assessment, multi-criteria decision analysis (MCDA), and patient-centred outcomes research. We support pharmaceutical and medical device companies across the entire development lifecycle - from pre-clinical to commercialization - generating patient-centric evidence that drives positive regulatory approval, market access, and commercial success.
Our patient-first philosophy enables clients to develop innovative therapies with real-world patient insights at their core. Through rigorous methodologies including discrete choice experiments, psychometric analyses, clinical trial exit interviews, and social media listening, we engage broad populations to optimize future treatments. We specialize in integrating patient voice into drug development, particularly for rare diseases, ensuring transformative therapies are developed with meaningful patient input from the outset.